VCEL Stock Analysis: Buy, Sell, or Hold?
VCEL - Vericel Corporation
$35.98
-0.52 (-1.42%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When VCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VCEL shows positive signals but monitor for confirmation. Market pricing in 1.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: VCEL shows positive signals but monitor for confirmation. Market pricing in 1.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$28.24
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$17.53
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCEL is currently trading at $35.98, which is considered oversold relative to its 30-day fair value range of $36.26 to $38.76. The stock's valuation (Forward PE: 62.9) is in line with its historical norms (65.3). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This pessimistic expectation contrasts with the company's recent 47.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VCEL is in a uptrend. The price is currently testing key support at $35.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VCEL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $55.00 (+50.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VCEL is in a uptrend. The price is currently testing key support at $35.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VCEL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $55.00 (+50.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$36.26 -
$38.76
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.7% below Wall St target ($55.00)
Fair Price Analysis
30-Day Fair Range
$36.26 -
$38.76
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$2.38
(6.6%)
Support & Resistance Levels
Support Level
$35.55
Resistance Level
$39.48
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
62.93
Wall Street Target
$55.00
(+50.7%)
Revenue Growth (YoY)
16.6%
Earnings Growth (YoY)
47.6%
Profit Margin
5.1%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
62.9 vs 65.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$36.06
(-1%)
2-Year Target
$35.63
(-2%)
3-Year Target
$35.20
(-4%)
3-Yr Target (if PE normalizes)
(PE: 63→65)
$36.53
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 62.9, Growth: 123.1%)
$123.19
(+238%)
Base:
(SPY PE: 22.3, Growth: 123.1%)
$43.65
(+20%)
Bear:
(PE: 19.0, Growth: 123.1%)
$37.10
(+2%)
📈
Valuation based on Current Earnings
Forward PE: 49.02 | Forward EPS (Implied): $0.73
Bull Case
$43.45
(+21%)
Analyst growth 15.0%, PE expands to 51.5
Base Case
$35.98
(0%)
Market implied 0.0%, PE stable at 49.0
Bear Case
$27.52
(-24%)
Severe decline -15.0%, PE contracts to 44.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 62.9 to 65.3
Stabilization Target:
$37.87
(+3.8%)
PE Expansion Potential:
+3.8%
Last updated: January 30, 2026 9:40 PM ET
Data refreshes hourly during market hours. Next update: 10:40 PM
Data refreshes hourly during market hours. Next update: 10:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced VCEL Option Strategies
Professional options setups generated by AI based on today's VCEL price and gamma walls.
